MANAGEMENT SERVICES AGREEMENTManagement Services Agreement • January 12th, 2017 • Avenue Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS MANAGEMENT SERVICES AGREEMENT (this “Agreement”) is effective as of February 17, 2015, by and between Avenue Therapeutics, Inc. a Delaware corporation (the “Company”), and Fortress Biotech, Inc., a Delaware corporation (the “Manager” and individually a “Party” or collectively the “Parties”).
AMENDED AND RESTATED FOUNDERS AGREEMENTFounders Agreement • January 12th, 2017 • Avenue Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED FOUNDERS AGREEMENT (this “Agreement”) is made as of September 13, 2016 (the “Effective Date”) by and between Fortress Biotech, Inc., a Delaware corporation (the “Founder”), and Avenue Therapeutics, Inc., a Delaware corporation (the “Company”).
Asset Transfer and License AgreementAssignment and Assumption Agreement • January 12th, 2017 • Avenue Therapeutics, Inc. • Pharmaceutical preparations • New York
This Asset Transfer and License Agreement (the “Agreement”), is entered into as of February 17, 2015 (the “Effective Date”), by and between Revogenex Ireland Limited, an Irish limited company (“Revogenex”), and Coronado Biosciences, Inc., a Delaware corporation (“Coronado”). Coronado and Revogenex are both referred to herein as “Parties” or each individually, as a “Party.”
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 12th, 2017 • Avenue Therapeutics, Inc. • Pharmaceutical preparations • New York
This Executive Employment Agreement (this “Agreement”) is made and entered into as of June 10, 2015 by and between Avenue Therapeutics, Inc. (the “Company”) and Lucy Lu, M.D. (“Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”.
CONSULTING AGREEMENTConsulting Agreement • January 12th, 2017 • Avenue Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS CONSULTING AGREEMENT (this “Agreement”), effective as of this 22 day of July, 2015 (“Effective Date”) is by and between Scott A. Reines, MD, PhD having an address set forth below (hereinafter referred to as “Consultant”) and Avenue Therapeutics, Inc. and its affiliates, having offices at 3 Columbus Circle, 1511’ Floor, New York, NY 10019 (“Avenue”).
FIRST AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • January 12th, 2017 • Avenue Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS FIRST AMENDMENT TO CONSULTING AGREEMENT (this “Amendment”) is made and entered into this 25th day of January, 2016 by and between Scott A. Reines, MD, PhD (“Consultant”) Avenue Therapeutics, Inc. and its affiliates, having offices at 3 Columbus Circle, 15th Floor, New York, NY 10019 (“Avenue”).
